News Announcement

Parmax Pharma: Reason For Delay In Filing Financial Statements For The Quarter Ended On 30Th September 2024.

we would like to inform you that the financial statements for the period ending on September 30 2024 were duly prepared and approved at the scheduled meeting of Board of Directors held on Thursday 14th November 2024. We apologize for this delay in filing due to circumstances beyond our control.We request you to condone this delay filing as all processes and approvals were completed within the required timeline.

वैल्यू रिसर्च धनक से पूछें aks value research information

कोई सवाल छोटा नहीं होता. पर्सनल फ़ाइनांस, म्यूचुअल फ़ंड्स, या फिर स्टॉक्स पर बेझिझक अपने सवाल पूछिए, और हम आसान भाषा में आपको जवाब देंगे.